Chang, Hung-YuHung-YuChangWang, Chun-ChiehChun-ChiehWangWei JengChang, Chong-YiChong-YiChangChuang, Yi-ChengYi-ChengChuangHuang, Chien-LongChien-LongHuangChong, EricEricChongJIUNN-LEE LINMar, Guang-YuanGuang-YuanMarChan, Kuei-ChuanKuei-ChuanChanKuo, Jen-YuanJen-YuanKuoWang, Ji-HungJi-HungWangChen, Zhih-CherngZhih-CherngChenTseng, Wei-KungWei-KungTsengCherng, Wen-JinWen-JinCherngYin, Wei-HsianWei-HsianYin2023-09-072023-09-072017-1217264901https://www.scopus.com/record/display.uri?eid=2-s2.0-85030699803&doi=10.1016%2fj.jcma.2017.04.011&origin=inward&txGid=94cf7ea3308c8a9f2cfe70cfca923407https://scholars.lib.ntu.edu.tw/handle/123456789/635154Heart failure (HF) is a global health problem. Guidelines for the management of HF have been established in Western countries and in Taiwan. However, data from the Taiwan Society of Cardiology-Heart Failure with reduced Ejection Fraction (TSOC-HFrEF) registry showed suboptimal prescription of guideline-recommended medications. We aimed to analyze the reason of non-prescription and clinical outcomes as a result of under-prescription of medications.enAdherence; Beta-blocker; Guidelines; Heart failure; Renin-angiotensin blockade; Taiwanjournal article10.1016/j.jcma.2017.04.011290331122-s2.0-85030699803